Global Immortalized Cell Line Market, By Method (Virus Induction, HTERT Expression, Inactivation of Tumor Suppression Genes, Others), Technology (SV40 Large T-Antigen, MycT58A, P53 Cell, Others), Application (Diagnostics, Drug Discovery, Vaccine Production, Tissue Engineering & Regenerative Medicine, Others), End-User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Research Laboratories), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Immortalized Cell Line Market
The immortalized cell line market is expected to witness market growth at a rate of approximately 9.30% in the forecast period of 2021 to 2028 and is expected to reach USD 7,031.44 million by 2028. Data Bridge Market Research report on immortalized cell line market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The increasing application in biotech and pharmaceutical companies and hospitals is escalating the growth of immortalized cell line market.
Immortalized cell lines refer to tumorous cells which are artificially manipulated or do not stop dividing for proliferating indefinitely. It can be cultured over various generations. Hep G2 and HepaRG cell lines are extensively used among the available human hepatic cell line for toxicity studies.
The rising demand along with applications of immortalized cell lines act as one of the major factors driving the growth of immortalized cell line market. The rise in the number of patients in need of organ transplantation and increasing rate of patient population affected by cancer accelerate the immortalized cell line market growth. The rise in the demand for organ donation due to scarcity in the availability of organs and high demand for artificially created biological cells further influence the immortalized cell line market. The increasing application in biotech and pharmaceutical companies and hospitals and acceptance of advanced treatment options also boost the immortalized cell line market. Additionally, growth in population, improving healthcare infrastructure, rise in awareness and surge in healthcare expenditure positively affects the immortalized cell line market. Furthermore, advancement and innovations extends profitable opportunities to the immortalized cell line market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the equipment is expected to obstruct the immortalized cell line market growth. Developing authentic and stable cell lines are projected to challenge the immortalized cell line market in the forecast period of 2021-2028.
This immortalized cell line market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on immortalized cell line market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Immortalized Cell Line Market Scope and Market Size
The immortalized cell line market is segmented on the basis of method, technology, application and end-user growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of method, the immortalized cell line market is segmented into virus induction, HTERT expression, inactivation of tumor suppression genes and others.
- On the basis of technology, the immortalized cell line market is segmented into SV40 large T-antigen, MycT58A, P53 cell and others.
- On the basis of application, the immortalized cell line market is segmented into diagnostics, drug discovery, vaccine production, tissue engineering and regenerative medicine and others.
- On the basis of end-user, the immortalized cell line market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations and research laboratories.
Global Immortalized Cell Line Market Country Level Analysis
The immortalized cell line market is analyzed and market size insights and trends are provided by country, method, technology, application and end-user as referenced above.
The countries covered in the immortalized cell line market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the immortalized cell line market due to the increase in the occurrence of cancer, increasing awareness of immortalized cell lines, strong research funding and well-established pharmaceutical and biotechnology industry. Europe is considered as the second largest market owning to growing government support, well-developed technology and rising cases of cancer. Asia-Pacific is expected to witness the highest growth rate during the forecast period of 2021 to 2028 because of the increasing expenditure on healthcare by government and private sector, growing awareness about healthcare and large untapped patient population in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The immortalized cell line market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for immortalized cell line market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the immortalized cell line market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Immortalized Cell Line Market Share Analysis
The immortalized cell line market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to immortalized cell line market.
The major players covered in the immortalized cell line market report are TCC, Thermo Fisher Scientific, Merck KGaA, Sigma-Aldrich Co., Lonza, General Electric Company, Selexis SA, Corning Incorporated, WuXi AppTec, Valneva SE, Sartorius AG, InSCREENeX GmbH, Creative Bioarray, Public Health England among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-